Medication info
Esora Tablet 40 Milligrams (Esomeprazole Magnesium Trihydrate)

Esora Tablet 40 Milligrams (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
NexPharm Korea Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/AluAlu x 2)
Approval status
Active

MFDS item code 201505853 · Approved 2015.08.20 · Insurance code 662503260

Summary

Main use
Treatment and prevention of gastroesophageal reflux, gastrointestinal disorders (e.g., ulcers and pain), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for the eradication of Helicobacter pylori Administer this medicine 20 mg twice daily for 7 days in combination with amoxicillin 1 g and clarithromycin 500 mg. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following initiation of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Since there is limited experience in patients with severe renal failure, this medicine should be administered with caution. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
NexPharm Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of gastroesophageal reflux, gastrointestinal disorders (e.g., ulcers and pain), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps alleviate symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the eradication of Helicobacter pylori in the treatment and prevention of duodenal ulcers and peptic ulcers. It is effective not only for treating upper gastrointestinal symptoms caused by non-steroidal anti-inflammatory drugs but also for treating and preventing gastric and duodenal ulcers. It is also utilized in the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding from gastric or duodenal ulcers. Thus, it is widely used for the treatment and prevention of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for the eradication of Helicobacter pylori Administer this medicine 20 mg twice daily for 7 days in combination with amoxicillin 1 g and clarithromycin 500 mg. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following initiation of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding from gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Since there is limited experience in patients with severe renal failure, this medicine should be administered with caution. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to individuals with known allergies to specific components or who have experienced hypersensitivity reactions. Additionally, people allergic to penicillin or macrolide antibiotics should exercise caution, and it is contraindicated in patients taking specific heart-related medications. Individuals who are breastfeeding or have a history of myocardial infarction should also avoid taking this medication for safety reasons. When taking this medication, various adverse reactions may occur; therefore, if symptoms such as headache, dizziness, indigestion, skin rash, or muscle pain arise, consultation with a doctor should be sought immediately. Prolonged use may lead to low magnesium levels, necessitating regular blood tests, and caution is advised for individuals with osteoporosis due to increased fracture risk. Moreover, as this medication reduces gastric acidity, the risk of gastrointestinal infections may slightly increase, and if diarrhea persists, medical attention should be sought. Due to numerous drug interactions, it is essential to inform healthcare providers about any current medications, particularly when used in conjunction with antiviral agents, antibiotics, anticoagulants, and anticonvulsants. The safety of this medication has not been sufficiently confirmed during pregnancy, thus individuals who are pregnant or plan to become pregnant should consult with a doctor before use. In cases of overdose, since there is no specific antidote, unintentional overdose should be treated immediately at a hospital. Store out of reach of children, and it is important to avoid transferring the medication to another container to maintain the safety and effectiveness of the medication.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell's syndrome, acute generalized pustular eruption, eosinophilia and systemic symptom-associated drug reactions, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal developmental disorders, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, impaired liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonicity, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disturbances, trembling, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, dysosmia, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/AluAlu x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.